Sat.Jul 10, 2021 - Fri.Jul 16, 2021

article thumbnail

Johnson & Johnson Recalls Sunscreen Because of Benzene Traces

NY Times

The company said it had determined that daily exposure to five Neutrogena and Aveeno sprays would not cause adverse health effects, but recalled the products out of an abundance of caution.

144
144
article thumbnail

AI-driven ‘clock’ predicts aging-related illness and mortality

pharmaphorum

Scientists in the US have developed an artificial intelligence-powered ‘clock’ that can estimate a person’s chance of developing an illness or dying based on the pattern of cytokines in their blood. The “inflammatory age” or iAge clock – described in the journal Nature Aging – uses a snapshot of the level of chronic inflammation in the body to predict the chances of developing cardiovascular or neurodegenerative diseases and to give an estimate of lifespan.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Aetion and Cegedim expand real-world data partnership

Pharma Times

In 2020, the two partners announced an initial collaboration to integrate Cegedim’s ‘THIN’ European real-world data into Aetion’s evidence platform

138
138
article thumbnail

ACD/Labs, Science Data Experts establish AI partnership

Outsourcing Pharma

The two companies will work together to come up with solutions that use machine learning and artificial intelligence to help accelerate innovation in R&D.

141
141
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

F.D.A. Attaches Warning of Guillain-Barré Syndrome to Johnson & Johnson Covid Vaccine

NY Times

Federal regulators concluded that the risk of developing the syndrome was low, and that the benefits of the vaccine still strongly outweigh it.

Vaccines 116
article thumbnail

Digitisation key to improving mental health services in England; report

pharmaphorum

Faced with a looming mental health crisis, the UK government has been urged to invest in the digitisation of service provision across the NHS in England in a new report from think tank Future Care Capital. The study’s author – FCC’s head of policy and research Dr Peter Bloomfield, argues that there has been a lack of support for mental health services for many years in the UK, and the pathways for accessing them are “convoluted, waiting lists are extensive, and outcomes are po

More Trending

article thumbnail

ReiThera’s COVID-19 vaccine looks to Phase 3 trial after preliminary Phase 2 data

Outsourcing Pharma

Antibody responses against the SARS-CoV-2 spike protein were found in 99% of volunteers after the second dose of ReiTheraâs COVID-19 vaccine candidate, according to Phase 2 preliminary data.

Vaccines 105
article thumbnail

Which pharmaceutical drugs have the most drug patents in Yugoslavia?

Drug Patent Watch

This chart shows the drugs with the most patents in Yugoslavia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Yugoslavia? appeared first on DrugPatentWatch - Make Better Decisions.

98
article thumbnail

UK fines drugmakers record £260m for price gouging NHS

pharmaphorum

The UK’s competition authority has issued its largest ever fine of more than £260 million ($360 million) to several pharma companies accused of colluding to hike the price of medicines delivered to the NHS. The Competition and Markets Authority (CMA) took the action against Auden Mckenzie and Actavis UK – now known as Accord-UK – and other companies after an investigation into the price of hydrocortisone tablets, which rose by 10,000% over a 10-year period.

119
119
article thumbnail

PHE study finds COVID-19 vaccines ‘highly effective’ in at-risk groups

Pharma Times

Vaccine effectiveness against symptomatic disease in at-risk groups is approximately 60% after one dose of either the AZ or Pfizer/BioNTech vaccines

Vaccines 136
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Lilly and Banner Alzheimer’s Institute in strategic research collaboration for donanemab trial

Outsourcing Pharma

Eli Lilly and Company and Banner Alzheimerâs Institute have announced a strategic research collaboration as part of the planned Phase 3 study for donanemab in participants at risk from cognitive and functional decline related to Alzheimerâs disease.

98
article thumbnail

DrugPatentWatch and Abbvie discuss Pharmaceutical Portfolio Management

Drug Patent Watch

Come join me and Wendi Lau from Abbvie as we participate in an interactive roundtable discussion on pharmaceutical portfolio management. We’ll be sharing our expertise and best practices for strategic…. The post DrugPatentWatch and Abbvie discuss Pharmaceutical Portfolio Management appeared first on DrugPatentWatch - Make Better Decisions.

94
article thumbnail

What HCPs think about health equity in cancer care

pharmaphorum

After more than a year of COVID-19 dominating health conversations, HCPs have been engaging in dialogue about continually evident disparities that many are facing in healthcare. CREATION.co’s Mary Kangley explores what HCPs think about health equity in cancer care. The topic rose to significance in the American Society of Clinical Oncology (ASCO) whereby they updated their mission statement in 2020 to “Conquering cancer through research, education, and promotion of the highest quality, equ

article thumbnail

NICE ‘no’ for Orchard Therapeutics’ gene therapy Libmeldy

Pharma Times

NICE concluded the cost-effectiveness estimates for Libmeldy are unlikely to be within the range that it would consider an effective use of NHS resources

128
128
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Savvy solutions can elevate medication adherence: AARDEX

Outsourcing Pharma

A representative from the medication management solutions company suggests patient behavior data can be used to improve adherence to trial drug regimens.

98
article thumbnail

OPDP Sends Untitled Letter

Eye on FDA

Upfront Author’s Note: This is the first posting in a while as I have been working to migrate the subscription service to a new provider. As such, some subscribers were lost in the process. Anyone who signed up for a subscription prior to 2019, would need to sign up again. Apologies for the inconvenience and thanks for your patience. Years ago, a single regulatory action letter issued by FDA’s Office of Prescription Drug Promotion (OPDP) would not have merited a blog posting in and o

article thumbnail

AZ, J&J tweaking COVID shots to reduce clotting risks; report

pharmaphorum

AstraZeneca and Johnson & Johnson are both exploring ways to modify their COVID-19 vaccines to minimise the risk of severe blood clotting reactions that are seen – albeit rarely – in some people receiving the jabs. At the same time, the UK’s National Institute for Health and Care excellence (NICE) is developing guidance to help doctors manage the cases of vaccine-induced immune thrombocytopenia and thrombosis (VITT) and low blood platelet counts that have been seen with the COVID-19 va

Vaccines 116
article thumbnail

Almost 50,000 extra doctors needed in England, says BMA

Pharma Times

BMA research finds the number of doctors per 1,000 people in England is 25 years behind comparable EU nations

130
130
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Pfizer, Biogen, and AbbVie collaborate on genetic database

Outsourcing Pharma

The genetic exome sequence analysis partnership has created a large database linking rare protein-coding genetic variants to human health and disease.

98
article thumbnail

U.S. Officials Push Back on Pfizer’s Request for Booster Shot Approval

NY Times

After meeting with company representatives, officials said the decision would depend partly on data on infections in vaccinated people that cause serious disease or hospitalization.

article thumbnail

Health Innovators – Jo Brewer, Adaptimmune

pharmaphorum

In this episode of Health Innovators , pharmaphorum founder Paul Tunnah interviews Jo Brewer, senior vice president of allogeneic research at UK company Adaptimmune which is transforming cancer immunotherapy with affinity enhanced T-cell receptors. Adaptimmune’s SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platform enables the engineering of T-cells to target and destroy cancer across multiple solid tumors.

article thumbnail

Galapagos’ filgotinib leads to rapid symptom improvement for ulcerative colitis patients

Pharma Times

Data also suggested filgotinib 200mg reduced and eliminated corticosteroid use compared to placebo

133
133
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Biden executive order could impact pharmaceutical industry

Outsourcing Pharma

US President Joe Biden singled out the pharmaceutical industry in his recently issued Executive Order on Promoting Competition in the American Economy.

100
100
article thumbnail

Ohio Clinic Says It Won't Administer Alzheimer's Drug to Patients

NY Times

The rejection of the new Alzheimer’s drug by the two major medical centers is one of the starkest signs of concern over its approval by the F.D.A.

84
article thumbnail

Why pharma needs a revolution in culture

pharmaphorum

James Dempsey breaks down the misconception that culture can’t be measured, and gives tips for how companies can implement a clear culture strategy. In 2014, six years after the global financial crisis forced the world’s biggest financial institutions into some serious navel gazing, the CEO of a major international bank was despairing: “We’ve put in place a best-in-class compliance system, but we can’t stop our people acting badly.

article thumbnail

Affinivax, Astellas’ pneumococcal vaccine wins breakthrough therapy status

Pharma Times

At the same time, Affinivax and Astellas revealed positive results from the Phase II trial of ASP3772

Vaccines 130
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Ongoing training fills data management knowledge gaps: TriTiCon

Outsourcing Pharma

A leader from the clinical tech consultancy shares advice on how to employ training to help keep up with the rapidly evolving field of data management.

80
article thumbnail

With the Delta Variant, Do I Need a Covid Booster Shot?

NY Times

Although studies of a third dose are underway, experts agree that the vaccines are still working well, even against the Delta variant, and that booster shots are not necessary right now.

article thumbnail

UK study raises hopes of long COVID test within months

pharmaphorum

A diagnostic test to detect long COVID could be available within six to 12 months, following the discovery that patients with the chronic condition have distinctive antibodies in their blood. . Researchers at Imperial College London (ICL) led by Professor Danny Altmann told the BBC’s Panorama programme that they have identified a pattern of antibodies in people with long COVID different from those who have fully recovered from COVID-19.

Immunity 105
article thumbnail

Merck’s MET inhibitor tepotinib gains positive opinion from MHRA

Pharma Times

The positive opinion has been issued via the MHRA’s early access the medicine (EAMS) scheme

130
130
article thumbnail

PMN 2021 Summer Summit: Evolving the Customer Experience

Pharma Marketing Network

Hear from leading Experience and Omnichannel experts from Merck , AstraZeneca , UCB , AbbVie , Harmony Biosciences , Genentech and more on winning strategies to transform data into actionable strategy, elevate CX beyond campaign optimization and activate the “Engagement Matrix” in your organization. Panel discussions include: Coordinated CX: Moving Beyond Campaign Management.

59